| Literature DB >> 35891911 |
Yuli Fang1,2, Yuanyuan Ma3,4, Haiyan He4, Ting Chen5, Jingjing Fu6, Jingci Zhu1.
Abstract
Objectives: This study aimed to investigate the application status of preventive measures for feeding intolerance in patients with severe traumatic brain injury (STBI) in China and analysis the differences and their causes.Entities:
Keywords: Craniocerebral trauma; Cross-sectional studies; Enteral nutrition; Medical staff; Patients; Protective agents
Year: 2022 PMID: 35891911 PMCID: PMC9304998 DOI: 10.1016/j.ijnss.2022.06.014
Source DB: PubMed Journal: Int J Nurs Sci ISSN: 2352-0132
Characteristics of participants (n = 996).
| Characteristics | |
|---|---|
| Sex | |
| Male | 151 (15.2) |
| Female | 845 (84.8) |
| Age (years) | |
| 18–35 | 815 (81.8) |
| 36–55 | 174 (17.5) |
| ≥56 | 7 (0.7) |
| Education level | |
| Technical or vocational education | 2 (0.2) |
| Junior college education | 278 (27.9) |
| Bachelor | 682 (68.5) |
| Master/Doctor/Ph.D | 34 (3.4) |
| Department | |
| General ICU | 657 (66.0) |
| Neurological ICU | 339 (34.0) |
| Occupation | |
| Doctor | 109 (10.9) |
| Nurse | 887 (89.1) |
| Professional title level | |
| Junior | 659 (66.2) |
| Intermediate | 294 (29.5) |
| Senior | 43 (4.3) |
| Work experience (years) | |
| ≤2 | 189 (19.0) |
| 3–5 | 281 (28.2) |
| 6–10 | 373 (37.5) |
| ≥11 | 153 (15.4) |
| Hospital classification | |
| Class A tertiary hospital | 722 (72.5) |
| Class B tertiary hospital or below | 274 (27.5) |
Gastrointestinal function assessment methods for patients with severe traumatic brain injury carried out by nurses and physicians (n = 996).
| Methods | Percentage of responses, % | Percentage of respondents, % | |
|---|---|---|---|
| Method for assessment of gastrointestinal function | |||
| Bowel sounds | 780 | 27.0 | 78.3 |
| Gastrointestinal symptoms (constipation, bowel distension, etc.) | 847 | 29.3 | 85.0 |
| Gastric residual volume | 819 | 28.3 | 82.2 |
| Motility of gastric antrum | 156 | 5.4 | 15.7 |
| AGI grade | 277 | 9.6 | 27.8 |
| Others (relying on dietitians’ assessment and patients’ nutritional status) | 13 | 0.5 | 1.3 |
| Method for predicting feeding intolerance | |||
| Assessment scale | 606 | 21.5 | 60.8 |
| Injury severity (GCS, APACHE-Ⅱ, etc.) | 711 | 25.2 | 71.4 |
| AGI grade | 485 | 17.2 | 48.7 |
| Basic characteristics of patients (age, sex, etc.) | 604 | 21.4 | 60.6 |
| Personal experience | 393 | 13.9 | 39.5 |
| Others (gastrointestinal symptoms) | 21 | 0.7 | 2.1 |
Note: All items are multiple-choice questions.
Supplementary answers from respondents. AGI = acute gastrointestinal injury grade. APACHE = acute physiology, and chronic health evaluation. GCS = Glasgow coma scale.
Delivery of enteral nutrition to patients with severe traumatic brain injury (n = 996).
| Characteristics | Percentage of responses, % | Percentage of respondents, % | |
|---|---|---|---|
| Initiation time of enteral nutrition | |||
| <24 h | 171 | 14.4 | 17.2 |
| Within 24–48 h | 612 | 51.6 | 61.5 |
| Within 48–72 h | 322 | 27.2 | 32.3 |
| Within 72–120 h | 72 | 6.1 | 7.2 |
| Others (according to patients’ conditions) | 9 | 0.8 | 0.9 |
| Primary enteral nutrition catheterization method | |||
| Nasogastric tube | 908 | 74.4 | 91.2 |
| Nasointestinal tube | 312 | 25.6 | 31.3 |
| Degree of head-of-bed elevation during enteral nutrition | |||
| <30° | 76 | 7.0 | 7.6 |
| 30°–45° | 891 | 82.6 | 89.5 |
| >45° | 108 | 10.0 | 10.8 |
| Others (according to patients’ intracranial pressure) | 4 | 0.4 | 0.4 |
| Infusion method during early enteral nutrition | |||
| Intermittent infusion (normal enteral nutrition solution) | 475 | 32.3 | 47.7 |
| Intermittent infusion (semi-solid enteral nutrition solution) | 136 | 9.3 | 13.7 |
| Continuous infusion by pump (normal enteral nutrition solution) | 726 | 49.4 | 72. 9 |
| Continuous infusion by gravity (normal enteral nutrition solution) | 133 | 9.1 | 13.4 |
| The temperature of the enteral nutrition solution | |||
| Near room temperature (22–25 °C) | 382 | 36.9 | 38.4 |
| Near body temperature (38–40 °C) | 652 | 63.1 | 65.5 |
| Initiation volume of enteral nutrition (ml) | |||
| <500 | 498 | 45.0 | 50.0 |
| 500–1,000 | 456 | 41.2 | 45.8 |
| 1,000–1,500 | 132 | 11.9 | 13.3 |
| >1,500 | 19 | 1.7 | 1.9 |
| Others (1,000–2,000 | 3 | 0.3 | 0.3 |
| GRV measurement | |||
| By syringe | 933 | 74.5 | 93.7 |
| By vacuum drainager | 220 | 17.6 | 22.1 |
| Ultrasound | 97 | 7.8 | 9.7 |
| Others (do not monitor GRV) | 2 | 0.2 | 0.2 |
| Frequency for monitoring GRV | |||
| Every 2 h | 163 | 12.5 | 16.4 |
| Every 4 h | 513 | 39.4 | 51.5 |
| Every 6 h | 142 | 10.9 | 14.3 |
| Each time before giving enteral nutrition solution | 482 | 37.0 | 48.4 |
| Others (during shift changes) | 2 | 0.2 | 0.2 |
| Definition of gastric retention | |||
| GRV >500 ml every 6 h | 368 | 32.5 | 37.0 |
| GRV >200 ml each time within 24 h | 575 | 50.8 | 57.7 |
| GRV >400 ml each time within 24 h | 180 | 15.9 | 18.1 |
| Others (GRV>500 ml every 24 h, GRV>100 ml every 4 h, GRV>200 ml every 4 h, GRV>500 ml every 4 h or GRV>500 ml each time within 24 h) | 8 | 0.7 | 0.8 |
Note: All items are multiple-choice questions.
Supplementary answers from respondents. GRV = gastric residual volume.
Preventive strategies of feeding intolerance among patients with severe traumatic brain injury (n = 996).
| Characteristics | Percentage of responses, % | Percentage of respondents, % | |
|---|---|---|---|
| Gastrointestinal motility promotion | |||
| In use ( | |||
| Traditional Chinese medicine (Dahuang, acupuncture, Dachengqi Tang, etc.) | 225 | 12.7 | 22.6 |
| Prokinetic agents (mosapride, metoclopramide, etc.) | 730 | 41.1 | 73.3 |
| Nursing strategy (abdominal massage, passive limb movement, etc.) | 584 | 32.9 | 58.6 |
| Others (regulation of gut microbiota) | 5 | 0.3 | 0.5 |
| Not use and reasons ( | |||
| No preventive effects | 48 | 2.7 | 4.8 |
| Unclear preventive effects | 137 | 7.7 | 13.8 |
| Side effects | 38 | 2.1 | 3.8 |
| Others (lack of awareness, health insurance restrictions, and no medical advice) | 8 | 0.5 | 0.8 |
| Defection facilitation | |||
| In use ( | |||
| Enema (glycerol, paraffin oil, etc.) | 733 | 41.6 | 73.6 |
| Laxative (polyethylene glycol, lactulose, etc.) | 548 | 31.1 | 55.0 |
| Nursing strategy (rectal stimulation, acupoint massage, etc.) | 283 | 16.1 | 28.4 |
| Others (herbs) | 7 | 0.4 | 0.7 |
| Not use and reasons ( | |||
| No preventive effects | 45 | 2.6 | 4.5 |
| Unclear preventive effects | 111 | 6.3 | 11.1 |
| Side effects | 25 | 1.4 | 2.5 |
| Others (no medical advice, no necessary to use) | 11 | 0.6 | 1.1 |
| Gut microbiota modulation | |||
| In use ( | |||
| Probiotics (live combined | 787 | 58.9 | 79.0 |
| Prebiotics (inulin, polydextrose, etc.) | 134 | 10.0 | 13.5 |
| Synbiotics | 189 | 14.2 | 19.0 |
| Not use and reasons ( | |||
| No preventive effects | 46 | 3.4 | 4.6 |
| Unclear preventive effects | 141 | 10.6 | 14.2 |
| Side effects | 26 | 2.0 | 2.6 |
| Others (health insurance restrictions) | 13 | 1.0 | 1.3 |
| Gastrointestinal mucosa protection | |||
| In use ( | |||
| Gastric mucosa protective agent (sucralfate, bismuth potassium citrate, etc.) | 529 | 29.4 | 53.1 |
| Antacid (lansoprazole, omeprazole, etc.) | 838 | 46.6 | 84.1 |
| Immune-enhancing agent (glutamine, ω-3 polyunsaturated fatty acid, etc.) | 352 | 19.6 | 35.3 |
| Not use and reasons ( | |||
| No preventive effects | 11 | 0.6 | 1.1 |
| Unclear preventive effects | 41 | 2.3 | 4.1 |
| Side effects | 16 | 0. 9 | 1.6 |
| Others (health insurance restrictions) | 10 | 0.6 | 1.0 |
| Initial enteral nutrition solution | |||
| Short peptide EN solution (Peptison Liquid, Peptisorb, etc.) | 410 | 25.1 | 41.2 |
| Intact protein EN solution (Enteral Nutritional Emulsion, Pepti son, etc.) | 553 | 33.9 | 55.5 |
| Non-nutritional preparation (glucose, warm water, etc.) | 653 | 40.0 | 65. 6 |
| Others (rice broth, milk, rice flour, or dependent on the decision of the nutrition department) | 18 | 1.1 | 1.8 |
Note: All items are multiple-choice questions.
Supplementary answers from respondents. EN = enteral nutrition.